論文 - 冨田 哲
-
Relationships between vascular endothelial growth factor levels and temperament and character inventory traits in healthy Japanese subjects.
Tetsu Tomita, Norio Yasui-Furukori, Shoko Tsuchimine, Ayako Kaneda, Sunao Kaneko
Neuropsychobiology 69 ( 1 ) 1 - 5 2014年02月
-
The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Sugawara N, Kaneko S
PloS one 9 ( 5 ) e98099 2014年
-
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response.
Tomita T, Yasui-Furukori N, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychiatric disease and treatment 10 599 - 606 2014年
-
Relationships between vascular endothelial growth factor levels and temperament and character inventory traits in healthy Japanese subjects.
Tomita T, Yasui-Furukori N, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychobiology 69 ( 1 ) 1 - 5 2014年
-
Anger is a distinctive feature of epilepsy patients with depression.
Mori Y, Kanemoto K, Onuma T, Tanaka M, Oshima T, Kato H, Tachimori H, Wada K, Kikuchi T, Tomita T, Chen L, Fang L, Yoshida S, Kato M, Kaneko S
The Tohoku journal of experimental medicine 232 ( 2 ) 123 - 128 2014年
-
Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan.
Sugawara N, Yasui-Furukori N, Tomita T, Furukori H, Kubo K, Nakagami T, Kaneko S
Neuropsychiatric disease and treatment 10 427 - 432 2014年
-
Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.
Tomita T, Yasui-Furukori N, Kaneko S
Clinical neuropharmacology 36 ( 5 ) 175 - 176 2013年09月
-
Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.
Tetsu Tomita, Norio Yasui-Furukori, Sunao Kaneko
Clinical neuropharmacology 36 ( 5 ) 175 - 176 2013年
-
Interaction between paliperidone extended release and TS-1(®), an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient.
Norio Yasui-Furukori, Kojiro Hashimoto, Kazutoshi Kubo, Tetsu Tomita
Neuropsychiatric disease and treatment 9 317 - 320 2013年
-
Interaction between paliperidone extended release and TS-1(®), an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient.
Yasui-Furukori N, Hashimoto K, Kubo K, Tomita T
Neuropsychiatric disease and treatment 9 317 - 319 2013年
-
Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.
Norio Yasui-Furukori, Ayako Kaneda, Norio Sugawara, Tetsu Tomita, Sunao Kaneko
Journal of psychopharmacology (Oxford, England) 26 ( 6 ) 806 - 812 2012年06月
-
Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.
Yasui-Furukori N, Kaneda A, Sugawara N, Tomita T, Kaneko S
Journal of psychopharmacology (Oxford, England) 26 ( 6 ) 806 - 812 2012年06月
-
The association between sunshine duration and paroxetine response time in patients with major depressive disorder.
Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, Ayako Kaneda, Sunao Kaneko
Journal of affective disorders 136 ( 3 ) 1067 - 1071 2012年02月
-
The association between sunshine duration and paroxetine response time in patients with major depressive disorder.
Tomita T, Yasui-Furukori N, Nakagami T, Kaneda A, Kaneko S
Journal of affective disorders 136 ( 3 ) 1067 - 1071 2012年02月
-
Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.
Norio Yasui-Furukori, Shoko Tsuchimine, Taku Nakagami, Akira Fujii, Yasushi Sato, Tetsu Tomita, Kaori Yoshizawa, Yoshimasa Inoue, Sunao Kaneko
Human psychopharmacology 26 ( 3 ) 194 - 200 2011年04月
-
Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.
Yasui-Furukori N, Tsuchimine S, Nakagami T, Fujii A, Sato Y, Tomita T, Yoshizawa K, Inoue Y, Kaneko S
Human psychopharmacology 26 ( 3 ) 194 - 200 2011年04月